專(zhuān)業(yè)英語(yǔ) Unit 25教案.docx
《專(zhuān)業(yè)英語(yǔ) Unit 25教案.docx》由會(huì)員分享,可在線(xiàn)閱讀,更多相關(guān)《專(zhuān)業(yè)英語(yǔ) Unit 25教案.docx(3頁(yè)珍藏版)》請(qǐng)?jiān)谘b配圖網(wǎng)上搜索。
1、UnitTwentyFive ADENOIDCYSTICCARCINOMAOFTHESA;IVARYGLAND SustainedCompleteResponsetoChemotherapy. G.THOMASBUDD.MD.AND.C.W.GROPPE.MD Apatientdevelopedwidelymetastaticadenoidcysticcarcinomaoftheparotidelandafterseverallocalrecurrences.Acompleteregressionofpleural,pulmonaryparenchymal,cutaneous,andb
2、onemetastaseswasseenfollowingtherapywith5-fluorouracil,Adriainycin,andmitomycinC.Thisisthesecondcompleteresponsetochemotherapyreportedforapatientwithmetastaticadenoidcysticcarcinomaofsalivaiyglandorigin.BothcompleteresponsesandseveralpartialresponseshavefollowedireatmeniwithAdriamycin,suggesting(hat
3、thisdrugisactiveinthedisease. Cancer51:589-590,1983 ADENOIDCYSTICCARCINOMAhasbeenanuncommon,slowgrowingtumorcharacterizedbymultiplerecurrences.Althoughthishistologicentityisoccasionallyrepresentedintumorsoftheskin,breastandcervix,aswellastumorsarisingfromlacrimalglandsand(heceruminousglandsoftheex
4、ternalauditorycanal,adenoidcysticcarcinomamostfrequentlyoriginatesinamajororminorsalivarygland.Thistumorwasfoundin10%ofpatientspresentingwithsalivaryneoplasmstoMemorialSloan-KetteringCancerCenterandin25%ofpatientspresentingtoM.D.AndersonHospitalwithneoplasmsofthemajorsalivaryglands(parotid,submaxill
5、ary,andsublingual),accountingfor5.2%ofallheadandneckcancers.Biologically,adenoidcysticcarcinomaischaracterizedbyslowgrowthwithinsidiousinvolvementoflocalstructures.Perineuralinvasionistypicalwhenthetumorislocatedinproximitytonervoustissue,andinfiltrativegrowthistherule.Clinically,thesecharacteristic
6、sarcmanifestasatendencyforlocalrecurrenceinapproximatelytwothirdsofpatients.Althoughdirectextensioncaninvolvelymphnodes,lymphaticspreadtoregionalnodesisnotcommon,occurringinonly15%ofthepatients.Distantmetastasesontheotherhand,occurin42-58%ofthepatients.Thelungsarefavoredsitesformetastases,althoughbo
7、ne,liver,centralnervoussystem,andotherorgansmaybecomeinvolved. Whilerelativelylongsurvivalcanoccurinthefaceofmetastaticdisease,effectivesystemictherapywouldbedesirableinviewofthetendencyforpatientswithadenoidcysticcarcinomatodevelopdistantmetastases.Theauthorsreportacompleteremissionfollowingtreatm
8、entwith5-fluorouracil.Adriamycin(doxorubicin),andmitomycinC,inapatientwithwidelymetastaticadenoidcysticcarcinomaoftheparotidgland. CaseReport InOctober1980,a29-year-oldwhitewomanwasreferredtotheClevelandClinicformetastaticadenoidcysticcarcinomaoriginatingintheleftparotidgland.Thepatienthadundergon
9、eresectionofaleftparotidtumorinSeptember1967foranadenoidcysticcarcinomashowinghistologicevidenceofearlyperineuralinvasion.AlocalrecurrenceinJanuary1972wastreatedbysurgicalresection.SubsequentlocalrecurrencesweretreatedbysubtotalparotidectomyinJanuary1976,andexcisioninJanuary1977,witharesectionofrecu
10、rrent(umorandaninvolvednodeinJanuary1978necessitatingsacrificeoftheleftfacialnerve.AlocalrecurrenceinOctober1978wastreatedwith300()radofmegavoltageradiationdeliveredbylinearacceleratoraswellas2000radoforthovoltageradiation. ThepatientfirstnotedchestpaininJuly1980,whichwasfollowedbythedevelopmentofd
11、yspneaonexertionandadrycoughinSeptember1980.Aright-sidedpleuraleffusionwasnotedandadecubituschestx-rayrevealedtwonodulardensitiesintherightmid-lungfields.Thoracentesiswasperformedandthefluidwasfoundtocontainmalignantcellscylologicallyconsistentwithmetastaticadenoidcysticcarcinoma.Abonescanshowedincr
12、easeduptakeoverthepubis.LI,T5andtherightribs;aliverspleenscanwasnormal.Serumchemistriesrevealedanelevationofthealkalinephosphataseto339U/L.Abiopsyspecimenofacutaneousnodulelocatedonthepatient'sabdomenrevealedmetastaticcarcinoma. OnOctober17,1980,thepatientreceivedherfirstcourseofcombinationchemothe
13、rapywithFAM.Treatmentwaswith5-fluorouracil500mg/ni2andAdriamycin30mg/m2intravenouslyeveryfourweeks.MitomycinCwasgivenonthefirstdayandeveryeightweeksatadosageof10nig/m2.ByFebruary26,1981,examinationofthepatient'schestx-rayshowedimprovementandtheserumalkalinephosphatasehadfallento118U/L.Abonescanperfo
14、rmedJune25,1981wasnormal.OnJuly2,1981,thepatient'schestXJraywasclearherserumalkalinephosphatasewasnormalat52U/L,andphysicalexaminationrevealednoevidenceofdisease.SheremainedincompleteremissionwhenseenonOctober30,1981.WhilestillreceivingtherapywithFAM,thepatientleadsaphysicallyactivelifeandremainsdis
15、easefreeafter12monthsoftreatment. Discussion Thisisthesecondreportedcaseofacompleteremissionofmetastaticadenoidcysticcarcinomaofthesalivaryglandinducedbychemotherapy.Theotherreportedcompleteresponseoccurredfollowingtherapywithvincristine,intravenouscyclophosphamide,andAdriamycin.inthatcase,disease
16、13rogressionhadoccurredduringtreatmentwithvincristineandoralcyclophosphamide,suggestingthatAdriamycinwastheagentresponsiblefortheinductionofremission.PartialresponseshavebeenreportedfollowingtherapywithAdriamycinandtherelatedanthracyclinedaunomycin.Offivepatientswithadvancedcarcinomaoftheparotidglan
17、dtreatedwithAdtiamycin,cisplatinandcyclophosphamide,twocompleteandthreepartialresponseswerereported,althoughnoneofthesepatienttumorsdemonstratedadenoidcystichistology.Asinglepartialresponsetohexamethylmelaniinetherapyhasbeenreported,althoughclassicalalkylatingagentshavenotbeeneffective.5-Fluorouraci
18、lhasbeenshowntohavesomeactivityagainstadenoidcysticcarcinomawhengiveneigberintra-arteriallyorintravenously. Althoughthedifficultiesinherenlintheretrospectiveassessmentofthebenefitsoftherapyinthisuncommonandslowgrowingtumorsystemhavebeenpointedout,objectiveresponsescanbedocumented.Inourpatient,aclea
19、r-cutimprovementinperformancestatusandlifestylehasaccompaniedamarkedimprovementinobjectivemeasuresofdisease,andaprolongationofsurvivalmightbepresumed.Adriamycinwouldseemtobethemosteffectiveagentforthetreatmentofmetastaticadenoidcysticcarcinomaofthesalivaryglands,although5-fluorouracilhasalsoshownsom
20、eactivity.Becausethetumorisuncommon,anyprospectivestudywouldbebatdonebyacooperativegroup,andshouldrecognizetheefficacyofAdriamycin,andperhaps5-fluorouracilinthetreatmentofthedisease. VOCABULARY 1. histologicentitycervix 2. perineuralinvasionlymphaticspread 3. 5-flaorouraciladriamycin 4. mitomy
21、cinmegavoltage 5. linearacceleratordyspnea 6. thoracentesisvincristine 7. daunomycincisplatin 8. clear-cutperformancestate 9. metastaticadenoidcysticcarcinoma 10. lacrimalglandsceruminousglands 11. parotidectomydecubitus 12. anthracyclinecyclophosphamide 組織學(xué)本質(zhì)子宮頸 神經(jīng)周擴(kuò)散淋巴道擴(kuò)散5一氟尿嗜啜阿霉素絲裂霉素巨電壓直線(xiàn)加速器呼吸困難胸腔穿刺術(shù)長(zhǎng)春新堿正定霉素順鉗明確的生活自理能力轉(zhuǎn)移的,遷移的腺樣囊性癌淚腺盯耳寧腺腮'腺切除臥位芯環(huán)類(lèi)抗生素環(huán)磷酰胺六甲蜜胺 13. hexamethylmelarnine
- 溫馨提示:
1: 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
2: 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
3.本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
5. 裝配圖網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年防凍教育安全教育班會(huì)全文PPT
- 2025年寒假安全教育班會(huì)全文PPT
- 初中2025年冬季防溺水安全教育全文PPT
- 初中臘八節(jié)2024年專(zhuān)題PPT
- 主播直播培訓(xùn)提升人氣的方法正確的直播方式如何留住游客
- XX地區(qū)機(jī)關(guān)工委2024年度年終黨建工作總結(jié)述職匯報(bào)
- 心肺復(fù)蘇培訓(xùn)(心臟驟停的臨床表現(xiàn)與診斷)
- 我的大學(xué)生活介紹
- XX單位2024年終專(zhuān)題組織生活會(huì)理論學(xué)習(xí)理論學(xué)習(xí)強(qiáng)黨性凝心聚力建新功
- 2024年XX單位個(gè)人述職述廉報(bào)告
- 一文解讀2025中央經(jīng)濟(jì)工作會(huì)議精神(使社會(huì)信心有效提振經(jīng)濟(jì)明顯回升)
- 2025職業(yè)生涯規(guī)劃報(bào)告自我評(píng)估職業(yè)探索目標(biāo)設(shè)定發(fā)展策略
- 2024年度XX縣縣委書(shū)記個(gè)人述職報(bào)告及2025年工作計(jì)劃
- 寒假計(jì)劃中學(xué)生寒假計(jì)劃安排表(規(guī)劃好寒假的每個(gè)階段)
- 中央經(jīng)濟(jì)工作會(huì)議九大看點(diǎn)學(xué)思想強(qiáng)黨性重實(shí)踐建新功